Published in Nature on May 01, 1997
Double muscling in cattle due to mutations in the myostatin gene. Proc Natl Acad Sci U S A (1997) 6.72
Regulation of myostatin activity and muscle growth. Proc Natl Acad Sci U S A (2001) 6.38
PDGF, TGF-beta, and heterotypic cell-cell interactions mediate endothelial cell-induced recruitment of 10T1/2 cells and their differentiation to a smooth muscle fate. J Cell Biol (1998) 5.21
Muscles, exercise and obesity: skeletal muscle as a secretory organ. Nat Rev Endocrinol (2012) 4.87
Fast/Glycolytic muscle fiber growth reduces fat mass and improves metabolic parameters in obese mice. Cell Metab (2008) 3.78
A mutation in the myostatin gene increases muscle mass and enhances racing performance in heterozygote dogs. PLoS Genet (2007) 3.61
Regulation of muscle growth by multiple ligands signaling through activin type II receptors. Proc Natl Acad Sci U S A (2005) 3.52
Cell size and invasion in TGF-beta-induced epithelial to mesenchymal transition is regulated by activation of the mTOR pathway. J Cell Biol (2007) 3.47
Requirement for serum response factor for skeletal muscle growth and maturation revealed by tissue-specific gene deletion in mice. Proc Natl Acad Sci U S A (2005) 3.30
Suppression of body fat accumulation in myostatin-deficient mice. J Clin Invest (2002) 3.28
Myostatin negatively regulates satellite cell activation and self-renewal. J Cell Biol (2003) 3.25
daf-28 encodes a C. elegans insulin superfamily member that is regulated by environmental cues and acts in the DAF-2 signaling pathway. Genes Dev (2003) 3.22
Myostatin signals through a transforming growth factor beta-like signaling pathway to block adipogenesis. Mol Cell Biol (2003) 2.90
Soft-tissue reconstruction of open fractures of the lower limb: muscle versus fasciocutaneous flaps. Plast Reconstr Surg (2012) 2.84
Muscle-specific expression of insulin-like growth factor I counters muscle decline in mdx mice. J Cell Biol (2002) 2.76
GDF11 Increases with Age and Inhibits Skeletal Muscle Regeneration. Cell Metab (2015) 2.71
Activation of latent myostatin by the BMP-1/tolloid family of metalloproteinases. Proc Natl Acad Sci U S A (2003) 2.66
MicroRNA-206: the skeletal muscle-specific myomiR. Biochim Biophys Acta (2008) 2.64
Cell lineages and the logic of proliferative control. PLoS Biol (2009) 2.62
Transforming growth factor-beta-regulated miR-24 promotes skeletal muscle differentiation. Nucleic Acids Res (2008) 2.44
Quadrupling muscle mass in mice by targeting TGF-beta signaling pathways. PLoS One (2007) 2.41
Myostatin activation in patients with advanced heart failure and after mechanical unloading. Eur J Heart Fail (2010) 2.40
Cellular and molecular mechanisms of muscle atrophy. Dis Model Mech (2013) 2.40
A PGC-1α isoform induced by resistance training regulates skeletal muscle hypertrophy. Cell (2012) 2.35
Long-term enhancement of skeletal muscle mass and strength by single gene administration of myostatin inhibitors. Proc Natl Acad Sci U S A (2008) 2.31
The bone morphogenetic protein 1/Tolloid-like metalloproteinases. Matrix Biol (2007) 2.27
Lack of myostatin results in excessive muscle growth but impaired force generation. Proc Natl Acad Sci U S A (2007) 2.25
Genetic deletion of myostatin from the heart prevents skeletal muscle atrophy in heart failure. Circulation (2010) 2.23
Follistatin gene delivery enhances muscle growth and strength in nonhuman primates. Sci Transl Med (2009) 2.21
BMP1 controls TGFbeta1 activation via cleavage of latent TGFbeta-binding protein. J Cell Biol (2006) 2.17
Molecular definition of an allelic series of mutations disrupting the myostatin function and causing double-muscling in cattle. Mamm Genome (1998) 2.15
Myostatin is a direct regulator of osteoclast differentiation and its inhibition reduces inflammatory joint destruction in mice. Nat Med (2015) 2.15
Skeletal muscle signature of a champion sprint runner. J Appl Physiol (1985) (2015) 2.14
Organization of the human myostatin gene and expression in healthy men and HIV-infected men with muscle wasting. Proc Natl Acad Sci U S A (1998) 2.13
Myostatin directly regulates skeletal muscle fibrosis. J Biol Chem (2008) 2.11
Regulation of skeletal muscle growth by the IGF1-Akt/PKB pathway: insights from genetic models. Skelet Muscle (2011) 2.10
Metabolic benefits of resistance training and fast glycolytic skeletal muscle. Am J Physiol Endocrinol Metab (2010) 2.06
Current status of pharmaceutical and genetic therapeutic approaches to treat DMD. Mol Ther (2011) 2.06
Myostatin inhibition in muscle, but not adipose tissue, decreases fat mass and improves insulin sensitivity. PLoS One (2009) 1.98
Myostatin regulates cardiomyocyte growth through modulation of Akt signaling. Circ Res (2006) 1.92
Muscle wasting in disease: molecular mechanisms and promising therapies. Nat Rev Drug Discov (2015) 1.90
High concentrations of HGF inhibit skeletal muscle satellite cell proliferation in vitro by inducing expression of myostatin: a possible mechanism for reestablishing satellite cell quiescence in vivo. Am J Physiol Cell Physiol (2009) 1.82
Muscle regeneration in the prolonged absence of myostatin. Proc Natl Acad Sci U S A (2005) 1.81
Contractile properties of EDL and soleus muscles of myostatin-deficient mice. J Appl Physiol (1985) (2006) 1.81
Regulation of muscle mass by follistatin and activins. Mol Endocrinol (2010) 1.79
Administration of a soluble activin type IIB receptor promotes skeletal muscle growth independent of fiber type. J Appl Physiol (1985) (2010) 1.76
Changes in muscle mass and phenotype and the expression of autocrine and systemic growth factors by muscle in response to stretch and overload. J Anat (1999) 1.75
Relative roles of TGF-beta1 and Wnt in the systemic regulation and aging of satellite cell responses. Aging Cell (2009) 1.72
Vitamin D reduces the expression of collagen and key profibrotic factors by inducing an antifibrotic phenotype in mesenchymal multipotent cells. J Endocrinol (2008) 1.72
Can exercise teach us how to treat heart disease? Circulation (2012) 1.70
BMP signaling controls muscle mass. Nat Genet (2013) 1.68
Pharmacological inhibition of myostatin suppresses systemic inflammation and muscle atrophy in mice with chronic kidney disease. FASEB J (2011) 1.67
Age-dependent effect of myostatin blockade on disease severity in a murine model of limb-girdle muscular dystrophy. Am J Pathol (2006) 1.64
Myostatin modulates adipogenesis to generate adipocytes with favorable metabolic effects. Proc Natl Acad Sci U S A (2006) 1.63
STAT3 activation in skeletal muscle links muscle wasting and the acute phase response in cancer cachexia. PLoS One (2011) 1.61
Bone morphogenetic protein and retinoic acid signaling cooperate to induce osteoblast differentiation of preadipocytes. J Cell Biol (2002) 1.58
ISSN exercise & sport nutrition review: research & recommendations. J Int Soc Sports Nutr (2010) 1.58
Tendons of myostatin-deficient mice are small, brittle, and hypocellular. Proc Natl Acad Sci U S A (2007) 1.57
Redundancy of myostatin and growth/differentiation factor 11 function. BMC Dev Biol (2009) 1.56
BMP-2 antagonists emerge from alterations in the low-affinity binding epitope for receptor BMPR-II. EMBO J (2000) 1.55
Muscle hypertrophy driven by myostatin blockade does not require stem/precursor-cell activity. Proc Natl Acad Sci U S A (2009) 1.55
GDF11 forms a bone morphogenetic protein 1-activated latent complex that can modulate nerve growth factor-induced differentiation of PC12 cells. Mol Cell Biol (2005) 1.54
Myostatin knockout drives browning of white adipose tissue through activating the AMPK-PGC1α-Fndc5 pathway in muscle. FASEB J (2013) 1.54
Shared and unique components of human population structure and genome-wide signals of positive selection in South Asia. Am J Hum Genet (2011) 1.52
Myostatin promotes the terminal differentiation of embryonic muscle progenitors. Genes Dev (2008) 1.52
Immunolocalization of myostatin (GDF-8) following musculoskeletal injury and the effects of exogenous myostatin on muscle and bone healing. J Histochem Cytochem (2012) 1.51
METABOLIC FUNCTIONS OF MYOSTATIN AND GDF11. Immunol Endocr Metab Agents Med Chem (2010) 1.50
Regulating activation of transplanted cells controls tissue regeneration. Proc Natl Acad Sci U S A (2006) 1.46
Characterization of growth-differentiation factor 15, a transforming growth factor beta superfamily member induced following liver injury. Mol Cell Biol (2000) 1.46
Identification of tgh-2, a filarial nematode homolog of Caenorhabditis elegans daf-7 and human transforming growth factor beta, expressed in microfilarial and adult stages of Brugia malayi. Infect Immun (2000) 1.46
Organ size control by Hippo and TOR pathways. Curr Biol (2012) 1.45
Signaling pathways controlling skeletal muscle mass. Crit Rev Biochem Mol Biol (2013) 1.43
Mitochondrial dysfunction in obesity. Curr Opin Endocrinol Diabetes Obes (2010) 1.42
Cellular mechanisms of tissue fibrosis. 4. Structural and functional consequences of skeletal muscle fibrosis. Am J Physiol Cell Physiol (2013) 1.41
miRNAS in normal and diseased skeletal muscle. J Cell Mol Med (2009) 1.41
Molecular and cellular mechanisms of skeletal muscle atrophy: an update. J Cachexia Sarcopenia Muscle (2012) 1.40
Myostatin does not regulate cardiac hypertrophy or fibrosis. Neuromuscul Disord (2007) 1.40
Inhibition of FoxO transcriptional activity prevents muscle fiber atrophy during cachexia and induces hypertrophy. FASEB J (2011) 1.39
Oversecretion of interleukin-15 from skeletal muscle reduces adiposity. Am J Physiol Endocrinol Metab (2008) 1.38
Transgenic expression of {alpha}7{beta}1 integrin maintains muscle integrity, increases regenerative capacity, promotes hypertrophy, and reduces cardiomyopathy in dystrophic mice. Am J Pathol (2005) 1.37
The role of myostatin in muscle wasting: an overview. J Cachexia Sarcopenia Muscle (2011) 1.36
Leptin administration favors muscle mass accretion by decreasing FoxO3a and increasing PGC-1alpha in ob/ob mice. PLoS One (2009) 1.36
Caveolinopathies: from the biology of caveolin-3 to human diseases. Eur J Hum Genet (2009) 1.36
Myostatin inhibits IGF-I-induced myotube hypertrophy through Akt. Am J Physiol Cell Physiol (2009) 1.35
Inhibition of myostatin with emphasis on follistatin as a therapy for muscle disease. Muscle Nerve (2009) 1.34
The depletion of skeletal muscle satellite cells with age is concomitant with reduced capacity of single progenitors to produce reserve progeny. Dev Biol (2010) 1.34
The effects of a soluble activin type IIB receptor on obesity and insulin sensitivity. Int J Obes (Lond) (2009) 1.34
Feedback regulation in multistage cell lineages. Math Biosci Eng (2009) 1.33
The structure of myostatin:follistatin 288: insights into receptor utilization and heparin binding. EMBO J (2009) 1.33
Atrogin-1, MuRF-1, and sarcopenia. Endocrine (2012) 1.33
Emerging roles for the transforming growth factor-{beta} superfamily in regulating adiposity and energy expenditure. Endocr Rev (2010) 1.32
Delivery of recombinant follistatin lessens disease severity in a mouse model of spinal muscular atrophy. Hum Mol Genet (2008) 1.32
Myostatin (GDF-8) as a key factor linking muscle mass and bone structure. J Musculoskelet Neuronal Interact (2010) 1.32
Loss-of-function mutation in myostatin reduces tumor necrosis factor alpha production and protects liver against obesity-induced insulin resistance. Diabetes (2009) 1.31
Animal models of Duchenne muscular dystrophy: from basic mechanisms to gene therapy. Dis Model Mech (2015) 1.30
Optimal management of sarcopenia. Clin Interv Aging (2010) 1.29
Canine models of Duchenne muscular dystrophy and their use in therapeutic strategies. Mamm Genome (2012) 1.28
Role of TGF-β signaling in inherited and acquired myopathies. Skelet Muscle (2011) 1.28
Cellular and developmental control of O2 homeostasis by hypoxia-inducible factor 1 alpha. Genes Dev (1998) 12.48
Double muscling in cattle due to mutations in the myostatin gene. Proc Natl Acad Sci U S A (1997) 6.72
Acceleration of oligomerization, not fibrillization, is a shared property of both alpha-synuclein mutations linked to early-onset Parkinson's disease: implications for pathogenesis and therapy. Proc Natl Acad Sci U S A (2000) 5.83
p27(Kip1) ubiquitination and degradation is regulated by the SCF(Skp2) complex through phosphorylated Thr187 in p27. Curr Biol (1999) 5.40
Structure and sequence of the rfb (O antigen) gene cluster of Salmonella serovar typhimurium (strain LT2). Mol Microbiol (1991) 4.76
Limb alterations in brachypodism mice due to mutations in a new member of the TGF beta-superfamily. Nature (1994) 3.99
Targeted disruption of the mouse factor VIII gene produces a model of haemophilia A. Nat Genet (1995) 3.74
Laparoscopic versus open gastric bypass: a randomized study of outcomes, quality of life, and costs. Ann Surg (2001) 2.96
Vesicle permeabilization by protofibrillar alpha-synuclein: implications for the pathogenesis and treatment of Parkinson's disease. Biochemistry (2001) 2.96
Regulation of anterior/posterior patterning of the axial skeleton by growth/differentiation factor 11. Nat Genet (1999) 2.90
Adverse effects of falciparum and vivax malaria and the safety of antimalarial treatment in early pregnancy: a population-based study. Lancet Infect Dis (2011) 2.65
cis-Acting sequences that mediate induction of beta-myosin heavy chain gene expression during left ventricular hypertrophy due to aortic constriction. Circulation (1997) 2.54
Rent1, a trans-effector of nonsense-mediated mRNA decay, is essential for mammalian embryonic viability. Hum Mol Genet (2001) 2.35
Single photon emission computed tomography-EEG relations in temporal lobe epilepsy. Neurology (1997) 2.03
Homeodomain-interacting protein kinases, a novel family of co-repressors for homeodomain transcription factors. J Biol Chem (1998) 1.90
Frequent alteration of p63 expression in human primary bladder carcinomas. Cancer Res (2000) 1.80
Obstetric ultrasound scanning by local health workers in a refugee camp on the Thai-Burmese border. Ultrasound Obstet Gynecol (2009) 1.80
Classical versus non-renal Wegener's granulomatosis. Q J Med (1994) 1.79
Investigation of mineral trioxide aggregate for root-end filling in dogs. J Endod (1995) 1.77
Introduction and expression of the 400 kilobase amyloid precursor protein gene in transgenic mice [corrected]. Nat Genet (1993) 1.74
A novel integrin specificity exemplified by binding of the alpha v beta 5 integrin to the basic domain of the HIV Tat protein and vitronectin. J Cell Biol (1993) 1.74
Microcystin production by Microcystis aeruginosa in a phosphorus-limited chemostat. Appl Environ Microbiol (2000) 1.72
Escherichia coli promoter opening and -10 recognition: mutational analysis of sigma70. EMBO J (2000) 1.71
Human saliva penetration of coronally unsealed obturated root canals. J Endod (1993) 1.70
GDF-3 and GDF-9: two new members of the transforming growth factor-beta superfamily containing a novel pattern of cysteines. J Biol Chem (1993) 1.68
Accelerated oligomerization by Parkinson's disease linked alpha-synuclein mutants. Ann N Y Acad Sci (2000) 1.67
Completely isolated enteric duplication cyst: case report. Abdom Imaging (2002) 1.66
Assessment of rituximab's immunomodulatory synovial effects (ARISE trial). 1: clinical and synovial biomarker results. Ann Rheum Dis (2007) 1.65
Spinocerebellar ataxia type 2 presenting as familial levodopa-responsive parkinsonism. Ann Neurol (2001) 1.63
Dietary influences on bone mass and bone metabolism: further evidence of a positive link between fruit and vegetable consumption and bone health? Am J Clin Nutr (2000) 1.63
Angiopoietin-1 is an apoptosis survival factor for endothelial cells. FEBS Lett (1999) 1.62
Isolated testicular vasculitis mimicking a testicular neoplasm. J Clin Pathol (1994) 1.59
Single bolus of intravenous ketamine for anesthetic induction decreases oculocardiac reflex in children undergoing strabismus surgery. Acta Anaesthesiol Scand (2007) 1.58
Further characterization of factor VIII-deficient mice created by gene targeting: RNA and protein studies. Blood (1996) 1.57
Loss of the chromosomal region 10q23-25 in prostate cancer. Cancer Res (1995) 1.57
Increased prevalence of renal biopsy findings other than diabetic glomerulopathy in type II diabetes mellitus. Nephrol Dial Transplant (1992) 1.54
Oligoclonal T lymphocytes in the cerebrospinal fluid of patients with multiple sclerosis. J Exp Med (1988) 1.52
Visual attention deficits contribute to impaired facial emotion recognition in boys with attention-deficit/hyperactivity disorder. Neuropediatrics (2009) 1.51
Physical mapping and microsynteny of Brassica rapa ssp. pekinensis genome corresponding to a 222 kbp gene-rich region of Arabidopsis chromosome 4 and partially duplicated on chromosome 5. Mol Genet Genomics (2005) 1.48
Acute diverticulitis of the cecum and ascending colon: the value of thin-section helical CT findings in excluding colonic carcinoma. AJR Am J Roentgenol (2000) 1.48
The acidic amino-terminal region of the HIV-1 Tat protein constitutes an essential activating domain. New Biol (1989) 1.47
Adult B-cell repertoire is biased toward two heavy-chain variable-region genes that rearrange frequently in fetal pre-B cells. Proc Natl Acad Sci U S A (1987) 1.46
Ergonovine echocardiography as a screening test for diagnosis of vasospastic angina before coronary angiography. J Am Coll Cardiol (1996) 1.46
Characterization of growth-differentiation factor 15, a transforming growth factor beta superfamily member induced following liver injury. Mol Cell Biol (2000) 1.46
Opposing role of mitogen-activated protein kinase subtypes, erk-1/2 and p38, in the regulation of chondrogenesis of mesenchymes. J Biol Chem (2000) 1.45
Prophylactic efficacy of a new gentamicin-releasing urethral catheter in short-term catheterized rabbits. BJU Int (2001) 1.44
Oocyte-specific expression of growth/differentiation factor-9. Mol Endocrinol (1995) 1.43
Hepatocellular carcinoma treated with percutaneous radio-frequency ablation: evaluation with follow-up multiphase helical CT. Radiology (2001) 1.43
Regulation of left-right patterning in mice by growth/differentiation factor-1. Nat Genet (2000) 1.43
Mice lacking ornithine-delta-aminotransferase have paradoxical neonatal hypoornithinaemia and retinal degeneration. Nat Genet (1995) 1.39
Splanchnic arterial stenosis or occlusion: diagnosis at Doppler US. Radiology (1999) 1.39
Prognostic factors for early severe pulmonary complications after hematopoietic stem cell transplantation. Biol Blood Marrow Transplant (2001) 1.38
Decision-making and quality of life in older adults with acute myeloid leukemia or advanced myelodysplastic syndrome. Leukemia (2004) 1.37
[Squamous cell carcinoma of the penis: treatment protocol according to our 14 years of experience]. Arch Esp Urol (1997) 1.37
A recombinant adenovirus expressing p27Kip1 induces cell cycle arrest and loss of cyclin-Cdk activity in human breast cancer cells. Oncogene (1997) 1.36
Regulation of cyclin D1 by calpain protease. J Biol Chem (1997) 1.36
Immediate exercise hyperemia in humans is contraction intensity dependent: evidence for rapid vasodilation. J Appl Physiol (1985) (2003) 1.36
Induction of cell cycle arrest and apoptosis in human breast cancer cells by quercetin. Int J Oncol (2001) 1.35
The cps gene cluster of Salmonella strain LT2 includes a second mannose pathway: sequence of two genes and relationship to genes in the rfb gene cluster. Mol Gen Genet (1991) 1.34
Brain structural mapping using a novel hybrid implicit/explicit framework based on the level-set method. Neuroimage (2005) 1.33
A nucleolar protein related to ribosomal protein L7 is required for an early step in large ribosomal subunit biogenesis. Proc Natl Acad Sci U S A (2000) 1.33
Fibroepithelial ureteral polyp--a case report; endoscopic removal of large ureteral polyp. J Korean Med Sci (1996) 1.32
Psychometric evaluation of a Chinese (Taiwanese) version of the SF-36 health survey amongst middle-aged women from a rural community. Qual Life Res (2000) 1.31
HLA-C mismatch is associated with inferior survival after unrelated donor non-myeloablative hematopoietic stem cell transplantation. Bone Marrow Transplant (2006) 1.31
Seasonal variation and indirect monitoring of microcystin concentrations in Daechung reservoir, Korea. Appl Environ Microbiol (2001) 1.30
Lower costs associated with hematopoietic cell transplantation using reduced intensity vs high-dose regimens for hematological malignancy. Bone Marrow Transplant (2007) 1.29
Stabilization of partially folded conformation during alpha-synuclein oligomerization in both purified and cytosolic preparations. J Biol Chem (2001) 1.29
Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation. Bone Marrow Transplant (2012) 1.28
High prevalence of metabolic syndrome after allogeneic hematopoietic cell transplantation. Bone Marrow Transplant (2008) 1.27
Low seroprevalence of HIV and syphilis in pregnant women in refugee camps on the Thai-Burma border. Int J STD AIDS (2008) 1.25
Malignant obstruction of gastric outlet and duodenum: palliation with flexible covered metallic stents. Radiology (2001) 1.25
Frequent epigenetic inactivation of RASSF1A in human bladder carcinoma. Cancer Res (2001) 1.23
Novel target sites for estrogen action in the dorsal hippocampus: an examination of synaptic proteins. Endocrinology (2001) 1.23
Family donor care management: principles and recommendations. Bone Marrow Transplant (2009) 1.23
Mitochondrial factors with dual roles in death and survival. Oncogene (2006) 1.23
Spectrophotometric determination of oxidized and reduced pyridine nucleotides in erythrocytes using a single extraction procedure. Anal Biochem (1987) 1.21
Resveratrol, an antioxidant present in red wine, induces apoptosis in human promyelocytic leukemia (HL-60) cells. Cancer Lett (1999) 1.20
A mouse model for X-linked adrenoleukodystrophy. Proc Natl Acad Sci U S A (1997) 1.20
Correlation between 99mTc-pertechnetate uptakes and expressions of human sodium iodide symporter gene in breast tumor tissues. Nucl Med Biol (2001) 1.20
Differential effects and transport kinetics of ascorbate derivatives in leukemic cell lines. Anticancer Res (1998) 1.20
Chronic graft-versus-host disease: implications of the National Institutes of Health consensus development project on criteria for clinical trials. Bone Marrow Transplant (2006) 1.17
Cardiopulmonary effects of diazepam. Clin Pharmacol Ther (1973) 1.17
Villous adenoma of the bile ducts: a case report and a review of the reported cases in Korea. Yonsei Med J (1999) 1.15
Growth/differentiation factor-10: a new member of the transforming growth factor-beta superfamily related to bone morphogenetic protein-3. Growth Factors (1995) 1.14
Angiopoietin-1 inhibits irradiation- and mannitol-induced apoptosis in endothelial cells. Circulation (2000) 1.14
An E-mail assessment of undergraduates' attitudes toward smoking. J Am Coll Health (1999) 1.14
Hypercholesterolemia in the rabbit induced by feeding graded amounts of low-level cholesterol. Methodological considerations regarding individual variability in response to dietary cholesterol and development of lesion type. Arterioscler Thromb Vasc Biol (1996) 1.13
Identification of proliferin mRNA and protein in mouse placenta. Proc Natl Acad Sci U S A (1985) 1.12
Controlled release of platelet-derived growth factor-BB from chondroitin sulfate-chitosan sponge for guided bone regeneration. J Control Release (2000) 1.11
A ginseng metabolite, compound K, induces autophagy and apoptosis via generation of reactive oxygen species and activation of JNK in human colon cancer cells. Cell Death Dis (2013) 1.11
Different modulation of Ca-activated K channels by the intracellular redox potential in pulmonary and ear arterial smooth muscle cells of the rabbit. Pflugers Arch (1995) 1.11
BetaPix-enhanced p38 activation by Cdc42/Rac/PAK/MKK3/6-mediated pathway. Implication in the regulation of membrane ruffling. J Biol Chem (2001) 1.11
Incidence and characterization of Listeria monocytogenes in foods available in Taiwan. Appl Environ Microbiol (1990) 1.11
Foci of eosinophil-related necrosis in the liver: imaging findings and correlation with eosinophilia. AJR Am J Roentgenol (1999) 1.11
Platelet derived growth factor releasing chitosan sponge for periodontal bone regeneration. Biomaterials (2000) 1.11
Altered metabolism of familial Alzheimer's disease-linked amyloid precursor protein variants in yeast artificial chromosome transgenic mice. Hum Mol Genet (1997) 1.10